The good thing is that there is still 31% capital growth until we hit fair value ($1).I got it wrong about the lack of sellers. 20% of share capital churned in 1.5 day. Plenty on the sell side.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025